Date
Resolution: Methotrimeprazine 25 mg/mL injectable is now available in good supply and this drug shortage can be considered resolved.
Practice Implications: Clinicians can return to using methotrimeprazine 25 mg/mL injectable as per usual practice. NH pharmacies can return to stocking usual quantities at their sites and providing wardstock in appropriate clinical areas.